GCG and endothelial dysfunction: Glucagon-like peptide-1 (GLP-1) agonists are potent glucose-lowering agents but also have potentially beneficial effects on other traditional [body weight, blood pressure (BP), and LDL cholesterol] and non-traditional risk factors (low-grade inflammation and endothelial dysfunction).